Loblaw Companies Limited · TSX:L
Loblaw Companies — Q4 2017 Earnings Presentation
6 slides from Loblaw Companies's earnings presentation, Feb 22, 2018
Slide 1: Q4 2017 Supplementary Slides
Q4 2017 Supplementary Slides February 22, 2018 1
Slide 2: Forward-looking Statements
Forward-looking Statements This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics Q4 - Consolidated
Key Financial Metrics Q4 Consolidated 2017 Margin/Growth B/(W) Consolidated Revenue $ 11,030M -0.9% (excluding disposition of gas bar operations) approx. +2.3% Adjusted EBITDA and Margin $ 1,013M 9.2%/+6.0% +60bps (excluding disposition of gas bar operations) approx.+8.2% approx. +50bps Adjusted Dil
Slide 4: Key Financial Metrics Q4 - Retail Segment
Key Financial Metrics Q4 Retail Segment 2017 Margin/Growth B/(W) Total Retail Revenue $ 10,718M -1.2% (excluding disposition of gas bar operations) approx. +2.1% Retail Revenue - Food Retail $ 7,546M -3.1% (excluding disposition of gas bar operations) approx. +1.4% Retail Revenue - Drug Retail $ 3,1
Slide 5: Key Operational Metrics Q4 - Food Retail (Loblaw)
Key Operational Metrics Q4 Food Retail (Loblaw) 2017 Food Retail SSS Growth ex gas bar 0.5% Basket Size Traffic Internal Food Price Index Loblaw Food Price Index was marginally higher than CPI of 1.0% Loblaw STM Square Footage Growth Industry STM Square Footage Growth 5
Slide 6: Key Operational Metrics Q4 - Drug Retail (Shoppers Drug Mart)
Key Operational Metrics Q4 Drug Retail (Shoppers Drug Mart) 2017 Pharmacy Sales $ 1,419M +4.3% Pharmacy SSS +3.9% # Rx Dispensed (Rx Count) Absolute + 4.5% Same-store basis +4.3% Average Rx Value -0.1% Front of Store Sales $ 1,753M +3.4% Front of Store SSS +3.5% 6